Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease.
Parkinson’s disease
Rel A
c-Rel ko mice
nuclear factor-κB (NF-κB)
α-synuclein
Journal
Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824
Informations de publication
Date de publication:
2020
2020
Historique:
received:
18
12
2019
accepted:
25
02
2020
entrez:
9
4
2020
pubmed:
9
4
2020
medline:
9
4
2020
Statut:
epublish
Résumé
The loss of dopaminergic neurons of the nigrostriatal system underlies the onset of the typical motor symptoms of Parkinson's disease (PD). Lewy bodies (LB) and Lewy neurites (LN), proteinaceous inclusions mainly composed of insoluble α-synuclein (α-syn) fibrils are key neuropathological hallmarks of the brain of affected patients. Compelling evidence supports that in the early prodromal phases of PD, synaptic terminal and axonal alterations initiate and drive a retrograde degeneration process culminating with the loss of nigral dopaminergic neurons. This notwithstanding, the molecular triggers remain to be fully elucidated. Although it has been shown that α-syn fibrillary aggregation can induce early synaptic and axonal impairment and cause nigrostriatal degeneration, we still ignore how and why α-syn fibrillation begins. Nuclear factor-κB (NF-κB) transcription factors, key regulators of inflammation and apoptosis, are involved in the brain programming of systemic aging as well as in the pathogenesis of several neurodegenerative diseases. The NF-κB family of factors consists of five different subunits (c-Rel, p65/RelA, p50, RelB, and p52), which combine to form transcriptionally active dimers. Different findings point out a role of RelA in PD. Interestingly, the nuclear content of RelA is abnormally increased in nigral dopamine (DA) neurons and glial cells of PD patients. Inhibition of RelA exert neuroprotection against (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) MPTP and 1-methyl-4-phenylpyridinium (MPP+) toxicity, suggesting that this factor decreases neuronal resilience. Conversely, the c-Rel subunit can exert neuroprotective actions. We recently described that mice deficient for c-Rel develop a PD-like motor and non-motor phenotype characterized by progressive brain α-syn accumulation and early synaptic changes preceding the frank loss of nigrostriatal neurons. This evidence supports that dysregulations in this transcription factors may be involved in the onset of PD. This review highlights observations supporting a possible interplay between NF-κB dysregulation and α-syn pathology in PD, with the aim to disclose novel potential mechanisms involved in the pathogenesis of this disorder.
Identifiants
pubmed: 32265684
doi: 10.3389/fnagi.2020.00068
pmc: PMC7105602
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
68Informations de copyright
Copyright © 2020 Bellucci, Bubacco, Longhena, Parrella, Faustini, Porrini, Bono, Missale and Pizzi.
Références
Cell. 2017 Sep 7;170(6):1096-1108.e13
pubmed: 28886380
Brain Pathol. 2014 Nov;24(6):584-98
pubmed: 24593806
Hum Mol Genet. 2017 Dec 15;26(24):4906-4915
pubmed: 29036344
Nat Med. 1999 May;5(5):554-9
pubmed: 10229233
J Biol Chem. 2008 Apr 4;283(14):9089-100
pubmed: 18245082
Sci Rep. 2019 Jan 24;9(1):544
pubmed: 30679445
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1385-1393
pubmed: 30025892
J Neurosci. 2001 Jul 1;21(13):4668-77
pubmed: 11425894
Int J Mol Sci. 2019 Jan 02;20(1):
pubmed: 30609739
Immun Ageing. 2013 Aug 05;10(1):31
pubmed: 23915308
Mov Disord. 2014 Jul;29(8):1010-8
pubmed: 24395122
Immunol Rev. 2012 Mar;246(1):36-58
pubmed: 22435546
Mov Disord. 2019 Oct;34(10):1406-1422
pubmed: 31483900
Free Radic Biol Med. 2012 Aug 15;53(4):993-1003
pubmed: 22705949
J Neurosci. 2002 Jul 1;22(13):5423-31
pubmed: 12097494
Eur J Neurosci. 2019 Feb;49(3):364-383
pubmed: 30474172
Sci Rep. 2016 Aug 04;6:30891
pubmed: 27488222
Stem Cells. 2010 Nov;28(11):1970-80
pubmed: 20882529
EMBO Mol Med. 2013 Jul;5(7):1119-27
pubmed: 23703938
Neuron. 2013 Sep 18;79(6):1044-66
pubmed: 24050397
Genes Dev. 2012 Feb 1;26(3):203-34
pubmed: 22302935
Sci Rep. 2019 Jul 29;9(1):10919
pubmed: 31358782
Biol Cell. 2019 Jun;111(6):161-168
pubmed: 30860281
Trends Neurosci. 2016 Nov;39(11):750-762
pubmed: 27776749
Synapse. 2000 Feb;35(2):151-9
pubmed: 10611641
Mol Biol Cell. 2010 Jun 1;21(11):1850-63
pubmed: 20392839
Mov Disord. 2008 Dec 15;23(16):2303-6
pubmed: 19006193
Cell Mol Neurobiol. 2008 Jan;28(1):35-47
pubmed: 17985233
Neurology. 2013 May 28;80(22):2055-61
pubmed: 23635961
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113
pubmed: 28104909
Mov Disord. 2013 Jan;28(1):31-40
pubmed: 23390095
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
Cell Res. 2011 Jan;21(1):103-15
pubmed: 21187859
Cell Mol Life Sci. 2017 Aug;74(15):2851-2874
pubmed: 28534083
Mol Neurodegener. 2010 Oct 26;5:42
pubmed: 20977765
Nat Med. 2005 Dec;11(12):1322-9
pubmed: 16286924
Transl Neurodegener. 2019 Aug 16;8:23
pubmed: 31428316
J Parkinsons Dis. 2019;9(s2):S331-S344
pubmed: 31609699
Oncotarget. 2017 Apr 13;8(32):52678-52689
pubmed: 28881761
Parkinsons Dis. 2019 Nov 3;2019:9237181
pubmed: 31781365
Nature. 2013 May 9;497(7448):211-6
pubmed: 23636330
Hum Mol Genet. 2006 Oct 15;15(20):3012-23
pubmed: 16959795
J Proteome Res. 2006 Sep;5(9):2396-404
pubmed: 16944952
Cell Metab. 2017 May 2;25(5):1091-1102.e4
pubmed: 28467927
Cell Tissue Res. 2018 Jul;373(1):175-182
pubmed: 29411106
Acta Neuropathol. 2017 Mar;133(3):381-393
pubmed: 28012041
J Mol Neurosci. 2005;26(1):27-32
pubmed: 15968083
Mov Disord. 2018 Jul;33(6):859-866
pubmed: 29178365
Front Aging Neurosci. 2017 Oct 10;9:330
pubmed: 29066967
Stroke. 2006 Jun;37(6):1533-8
pubmed: 16627788
Brain Pathol. 2016 May;26(3):398-403
pubmed: 26940375
Mol Psychiatry. 2019 Nov 22;:
pubmed: 31758091
Nutr Healthy Aging. 2018 Jun 15;4(4):267-285
pubmed: 29951588
Acta Neuropathol. 2018 Oct;136(4):621-639
pubmed: 30046897
J Clin Invest. 2002 Sep;110(6):843-50
pubmed: 12235116
J Parkinsons Dis. 2013;3(4):493-514
pubmed: 24275605
Mov Disord. 2016 Feb;31(2):161-8
pubmed: 26347034
Neurosci Res. 2006 Aug;55(4):434-41
pubmed: 16759729
Front Aging Neurosci. 2017 Jul 19;9:229
pubmed: 28769786
J Neuroinflammation. 2012 Nov 27;9:259
pubmed: 23186369
Evid Based Complement Alternat Med. 2014;2014:542383
pubmed: 24799940
Cell Mol Neurobiol. 2008 Jan;28(1):21-33
pubmed: 17712623
Acta Neuropathol Commun. 2019 Mar 14;7(1):41
pubmed: 30871620
Nat Neurosci. 2017 May;20(5):681-689
pubmed: 28288128
Neurobiol Dis. 2018 Nov;119:121-135
pubmed: 30092270
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
J Gerontol A Biol Sci Med Sci. 2014 Dec;69(12):1536-44
pubmed: 25136002
J Cereb Blood Flow Metab. 2011 Mar;31(3):913-23
pubmed: 20877387
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
FEBS J. 2009 Jan;276(1):27-35
pubmed: 19087197
Mol Cell Biol. 2000 Apr;20(8):2687-95
pubmed: 10733571
J Biol Chem. 2011 Jun 10;286(23):20710-26
pubmed: 21489994
Int J Biochem Cell Biol. 1997 Dec;29(12):1433-48
pubmed: 9570137
Brain. 2010 Jul;133(Pt 7):2032-44
pubmed: 20534649
J Neurosci. 2004 Oct 20;24(42):9434-40
pubmed: 15496679
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18754-9
pubmed: 18000063
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1931-6
pubmed: 26839413
Curr Biol. 2015 Sep 21;25(18):2349-60
pubmed: 26320949
J Neurosci. 2016 Jun 29;36(26):7055-65
pubmed: 27358461
Mov Disord. 2010 Jun 15;25(8):1091-6
pubmed: 20198645
J Neurosci. 2012 Mar 7;32(10):3306-20
pubmed: 22399753
J Neurosci. 2006 Dec 13;26(50):12896-903
pubmed: 17167080
Free Radic Biol Med. 2007 Nov 15;43(10):1351-71
pubmed: 17936181
Science. 2006 Jul 21;313(5785):324-8
pubmed: 16794039
Trends Neurosci. 2005 Jan;28(1):37-43
pubmed: 15626495
Brain Sci. 2016 May 26;6(2):
pubmed: 27240409
Int Rev Neurobiol. 2009;85:351-62
pubmed: 19607980
Cell Death Differ. 2006 May;13(5):852-60
pubmed: 16397579
Neurol Sci. 2016 May;37(5):749-54
pubmed: 26829934
J Neurochem. 2019 Sep;150(5):475-486
pubmed: 31269263
Curr Opin Toxicol. 2018 Feb;7:81-86
pubmed: 29862377
J Neuroinflammation. 2016 Sep 06;13(1):237
pubmed: 27596278
Mol Cell Biochem. 2013 Jun;378(1-2):237-46
pubmed: 23479382
Nat Cell Biol. 2007 Sep;9(9):1081-8
pubmed: 17704767
Cell Death Differ. 2005 Jul;12(7):761-72
pubmed: 15818410
J Clin Invest. 2008 Feb;118(2):777-88
pubmed: 18172548
Biochemistry. 2003 Jul 22;42(28):8465-71
pubmed: 12859192
Curr Biol. 2014 Oct 6;24(19):2319-26
pubmed: 25264250
Nature. 2017 Jun 29;546(7660):656-661
pubmed: 28636593
J Neurosci Res. 2011 Jul;89(7):1091-102
pubmed: 21488084
Ann N Y Acad Sci. 2000;920:16-27
pubmed: 11193145
Eur J Neurosci. 2006 Apr;23(7):1711-20
pubmed: 16623827
J Neurochem. 2011 Feb;116(4):588-605
pubmed: 21166675
Autophagy. 2007 Jul-Aug;3(4):390-2
pubmed: 17471012
Brain. 2012 Sep;135(Pt 9):2750-65
pubmed: 22915735
J Neurochem. 2006 Jun;97(6):1634-58
pubmed: 16805774
Nat Rev Drug Discov. 2004 Jan;3(1):17-26
pubmed: 14708018
Glia. 2019 Aug;67(8):1449-1461
pubmed: 30957303
Free Radic Biol Med. 2012 Jul 15;53(2):383-94
pubmed: 22580300
J Neural Transm (Vienna). 2008 May;115(5):669-76
pubmed: 18094921
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2669-74
pubmed: 20133768
Brain Pathol. 2002 Oct;12(4):499-510
pubmed: 12408237
PLoS One. 2012;7(5):e38019
pubmed: 22666436
J Neurosci. 2000 May 1;20(9):3214-20
pubmed: 10777786
Cancer Res. 2001 Mar 15;61(6):2656-64
pubmed: 11289144
J Clin Invest. 2012 Jul;122(7):2601-12
pubmed: 22706308
Mol Biol Cell. 2016 Jun 1;27(11):1712-27
pubmed: 27075172
Cell Rep. 2018 Nov 20;25(8):2110-2120.e3
pubmed: 30463009
Parkinsons Dis. 2015;2015:108029
pubmed: 25918668
Front Immunol. 2019 May 09;10:1043
pubmed: 31143184
Cell Cycle. 2008 Mar 1;7(5):556-9
pubmed: 18256548
Cell Death Dis. 2010 Nov 04;1:e96
pubmed: 21368872
Neuroscience. 2004;127(4):913-20
pubmed: 15312903
J Neurosci. 2014 Jan 1;34(1):249-59
pubmed: 24381286
Front Neurosci. 2019 Apr 24;13:369
pubmed: 31068777
Trends Mol Med. 2013 Mar;19(3):165-75
pubmed: 23352769
J Neurochem. 2009 Jan;108(2):475-85
pubmed: 19094066
Ageing Res Rev. 2014 Mar;14:19-30
pubmed: 24503004
Nat Neurosci. 2003 Feb;6(2):161-7
pubmed: 12514737
Clin Dev Immunol. 2012;2012:239368
pubmed: 22481964
Stroke. 2009 Feb;40(2):610-7
pubmed: 19023096
Neuropathol Appl Neurobiol. 2016 Feb;42(1):77-94
pubmed: 26613567
Brain Res. 1998 Mar 30;788(1-2):311-4
pubmed: 9555070
Front Neurol. 2015 May 20;6:98
pubmed: 26042083
Nat Rev Neurosci. 2011 Jun;12(6):359-66
pubmed: 21587290
Cell Tissue Res. 2018 Jul;373(1):1-7
pubmed: 29882128
Nat Med. 2008 May;14(5):504-6
pubmed: 18391962
Mov Disord. 2008 Jan;23(1):47-53
pubmed: 17960810
Science. 2002 Mar 22;295(5563):2282-5
pubmed: 11910117
Brain. 2016 Mar;139(Pt 3):856-70
pubmed: 26719384
Mol Cell Biol. 2005 Nov;25(22):10190-201
pubmed: 16260631
Biochim Biophys Acta. 2016 Mar;1862(3):339-51
pubmed: 26524636
Int J Neuropsychopharmacol. 2012 Feb;15(1):77-90
pubmed: 21329555
Hum Mol Genet. 2019 Jan 1;28(1):31-50
pubmed: 30219847
J Neuropathol Exp Neurol. 2007 Oct;66(10):955-64
pubmed: 17917589
Brain Res. 2012 Oct 2;1476:183-202
pubmed: 22560500
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7531-6
pubmed: 9207126
Curr Opin Neurol. 2016 Aug;29(4):459-66
pubmed: 27257944
Front Neuroanat. 2014 Dec 18;8:159
pubmed: 25565982
Brain Res. 2012 Jan 13;1432:95-113
pubmed: 22153624
J Biol Chem. 2002 Jun 7;277(23):20717-23
pubmed: 11912207
J Neurosci. 1998 May 1;18(9):3251-60
pubmed: 9547234
Prog Neurobiol. 2019 Jun;177:73-93
pubmed: 30219247
Nat Rev Mol Cell Biol. 2004 May;5(5):392-401
pubmed: 15122352
PLoS One. 2010 Jul 29;5(7):e11875
pubmed: 20686703
J Neurol Sci. 2001 Feb 15;184(1):71-5
pubmed: 11231035
Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):7813-7818
pubmed: 29991596
Transl Neurodegener. 2019 May 21;8:16
pubmed: 31139367
Front Immunol. 2017 Dec 11;8:1805
pubmed: 29312321
Neuroscientist. 2013 Apr;19(2):175-94
pubmed: 22785105
Nat Commun. 2019 Mar 1;10(1):994
pubmed: 30824768
Neurobiol Dis. 2017 Jul;103:101-112
pubmed: 28411117
Nat Rev Immunol. 2002 Oct;2(10):725-34
pubmed: 12360211
Curr Med Chem. 2019;26(20):3719-3753
pubmed: 30306855
Sci Rep. 2016 Jun 08;6:27125
pubmed: 27273030
J Neurosci. 2012 Mar 7;32(10):3301-5
pubmed: 22399752
Mol Cell Neurosci. 2014 Nov;63:114-23
pubmed: 25447944
Oxid Med Cell Longev. 2019 Nov 23;2019:4246350
pubmed: 31871549
J Neurosci. 2011 Jun 22;31(25):9159-69
pubmed: 21697367
Nat Med. 2009 Sep;15(9):1016-22
pubmed: 19701202
FEBS J. 2018 Oct;285(19):3657-3668
pubmed: 30028088
J Neurosci. 2017 Oct 11;37(41):9808-9818
pubmed: 29021298
J Parkinsons Dis. 2015;5(4):699-713
pubmed: 26407041
Mol Neurobiol. 2013 Apr;47(2):561-74
pubmed: 22544647
Ann N Y Acad Sci. 2010 Jan;1184:55-67
pubmed: 20146690
Neuropathology. 2017 Apr;37(2):129-149
pubmed: 27862327
NPJ Parkinsons Dis. 2018 Mar 26;4:9
pubmed: 29872690
Inflamm Bowel Dis. 1997 Fall;3(3):230-5
pubmed: 23282809
J Parkinsons Dis. 2011;1(1):83-92
pubmed: 23939259
Redox Biol. 2020 Feb;30:101427
pubmed: 31986466
Sci Rep. 2017 Jul 25;7(1):6363
pubmed: 28743955
Trends Neurosci. 2017 Jan;40(1):4-14
pubmed: 27894611
Endocrinology. 2007 May;148(5):2563-70
pubmed: 17317773
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3213-9
pubmed: 22315428
J Neurosci. 2014 Jun 11;34(24):8210-8
pubmed: 24920625
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2642-7
pubmed: 9122249
Nat Neurosci. 2003 Oct;6(10):1072-8
pubmed: 12947408